Vaxcyte Inc
(PCVX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 281,080 | 306,744 | 346,850 | 387,878 | 1,050,189 |
| Marketable Securities | 1,430,240 | 1,354,683 | 1,324,881 | 1,359,330 | 1,130,276 |
| TOTAL | $1,767,167 | $1,715,775 | $1,716,563 | $1,787,985 | $2,213,865 |
| Non-Current Assets | |||||
| PPE Net | 253,486 | 242,266 | 217,155 | 198,045 | 163,243 |
| Investments And Advances | 959,256 | 1,165,091 | 1,279,031 | 1,387,510 | 1,092,574 |
| Other Non-Current Assets | 191,691 | 182,231 | 165,354 | 137,778 | 90,064 |
| TOTAL | $1,404,433 | $1,589,588 | $1,661,540 | $1,723,333 | $1,345,881 |
| Total Assets | $3,171,600 | $3,305,363 | $3,378,103 | $3,511,318 | $3,559,746 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 48,962 | 31,414 | 20,514 | 48,452 | 18,219 |
| Accrued Expenses | 24,592 | 32,214 | 26,042 | 29,123 | 30,753 |
| TOTAL | $200,046 | $154,486 | $96,996 | $140,180 | $123,790 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 78,672 | 79,543 | 81,081 | 65,319 | 18,322 |
| TOTAL | $78,672 | $79,543 | $81,081 | $65,319 | $18,322 |
| Total Liabilities | $278,718 | $234,029 | $178,077 | $205,499 | $142,112 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 130,906 | 129,823 | 129,004 | 128,762 | 124,637 |
| Common Shares | 133 | 133 | 132 | 128 | 127 |
| Retained earnings | -1,908,440 | -1,695,610 | -1,529,037 | -1,388,319 | -1,251,239 |
| Other shareholders' equity | 856 | -1,887 | -322 | -3,873 | 139 |
| TOTAL | $2,892,882 | $3,071,334 | $3,200,026 | $3,305,819 | $3,417,634 |
| Total Liabilities And Equity | $3,171,600 | $3,305,363 | $3,378,103 | $3,511,318 | $3,559,746 |